Form 13-F position report

PROTEOSTASIS THERAPEUTICS I

Reported by NORTHERN TRUST CORPORATION

PTI CUSIP 74373B109 Manager CIK 0000073124

Reported 0 shares, down 80,710 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2020
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 20 Through Q4 2020

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for PROTEOSTASIS THERAPEUTICS I held by NORTHERN TRUST CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

41 managers reported PROTEOSTASIS THERAPEUTICS I for Q4 2020.

Managers reporting PROTEOSTASIS THERAPEUTICS I in Q4 2020.
Manager Activity Shares Change % of reported 13F Reported value Tenure
UBS Group AG Reduced 0 -5,874 0 $0 5 qtrs
MORGAN STANLEY Reduced 0 -4,000 0 $0 19 qtrs
GSA CAPITAL PARTNERS LLP Reduced 0 -119,284 0 $0 7 qtrs
NORTHERN TRUST CORPORATION This report Reduced 0 -80,710 0 $0 20 qtrs
Bank of America Corporation Reduced 0 -4,794 0 $0 2 qtrs
CAROLINAS WEALTH CONSULTING LLC Reduced 0 -100 0 $0 3 qtrs
VANGUARD GROUP INC Reduced 0 -1,781,400 0 $0 19 qtrs
Bain Capital Public Equity Management II LLC Reduced 0 -659,350 0 $0 7 qtrs
Cutler Group LLC CA Reduced 0 -3,900 0 $0 12 qtrs
BlackRock Inc Reduced 0 -1,085,207 0 $0 19 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2020
Filed
February 11, 2021
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.